분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2010-09-17 08:35:26 , Hit : 2958
 Gene Therapy Appears to Help Patient With Anemia

By Maggie Fox, Health and Science Editor
September 15, 2010

WASHINGTON (Reuters) - A patient with a rare genetic form of anemia is getting by without blood transfusions after experimental gene therapy, French and U.S. researchers reported on Wednesday.

The case, reported in the journal Nature, is a rare success for the troubled field of gene therapy, although the researchers and other experts said it still needs fine-tuning.

The patient has beta-thalassemia, a group of conditions caused by genetic defects in the production of hemoglobin. Researchers used gene therapy to fix the faulty gene responsible for the condition in some of the patient's own bone marrow stem cells, and re-infused them.

Nearly three years later, the patient has been healthy without the need for the usual blood transfusions, the team at Brigham & Women's Hospital and Harvard Medical School in Boston and University of Paris reported.

"For the first time, a patient with severe beta-thalassemia is living without the need for transfusions over a sustained period of time," Dr. Marina Cavazzana-Calvo of the University of Paris and the Necker Hospital said in a statement.

Gene therapy is a promising but difficult approach to medicine, based on the idea that faulty genes that underlie many diseases can be corrected.

Researchers have struggled to find good ways to get the repaired genes back into the body safely. Viruses are usually used to carry the genes into the body and they can themselves be dangerous.

One experiment cured two French boys with a rare immune disorder but gave them leukemia in 2002, and an Arizona teenager died in a 1999 gene therapy experiment, evidently from an immune system overreaction to the virus that was used.

But researchers at Children's Hospital of Philadelphia have used gene therapy to help improve worsening eyesight in 12 patients with a rare blinding disease called Leber congenital amaurosis, or LCA.

For the beta-thalassemia study, the researchers used a modified AIDS virus to repair the DNA in the patient's bone marrow stem cells.

A small, Massachusetts-based biotech company called Bluebird Bio is developing the approach as a product called LentiGlobin.

In an unusual step, they first destroyed the patient's bone marrow -- a method used before giving patients bone marrow transplants for cancer and other conditions.

The patient got the first transfusion in 2007, when he was 18, and again in 2008. "At present, approximately 3 years post-transplantation, the biological and clinical evolution is remarkable, and the patient's quality of life is good," the researchers wrote in Nature.

Dr. Derek Persons of St. Jude Children's Research Hospital in Memphis, Tennessee, said destroying the patient's bone marrow appears to have been crucial to making the treatment work.

"Although, three years on, he remains mildly anemic and shows signs of compensatory expansion of red-blood cell precursors in his bone marrow, absence of the need for blood transfusions means that this case can be viewed as a clinical success," Parsons, who was not involved in the research, wrote in a commentary.

Beta-thalassemia is diagnosed in about 60,000 children globally each year.

It is caused by defects in a gene involved in making hemoglobin, the component that carries iron in red blood cells, and patients generally need monthly blood transfusions to treat severe anemia and then special therapy called chelation to clear out the extra iron buildup caused by the transfusions.

Copyright 2010 Reuters News Service. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.









787   Gene Editing Treats Blood Disease  이성욱 2011/07/16 3063
786   A pathogenic picornavirus acquires an envelope by hijacking cellular membranes  이성욱 2013/04/23 3055
785   The Sugar Lnc  이성욱 2012/05/10 3031
784   A targeted cancer therapy? - small conditional RNA  이성욱 2010/09/08 3018
783   More support for transcription trickPosted by Jef Akst  이성욱 2010/05/01 3002
782   Roche hepatitis C drug appears safe in combination  이성욱 2010/10/17 3000
781   면역 시스템을 가지는 바이러스  이성욱 2013/03/01 2991
780   유전자 특허 불인정 판결의 후폭풍: 멘붕에 빠진 미 BT 업계  이성욱 2013/06/20 2980
779   배아 발달 동안 돌연변이와 성인에서 암 발병 관련성  이성욱 2012/06/18 2979
778   Hepatitis C Virus Infection Linked to Fat Enzyme in Liver Cells  이성욱 2010/10/15 2976
777   Sugars recruited in fight against persistent infections  이성욱 2011/05/17 2961
  Gene Therapy Appears to Help Patient With Anemia  이성욱 2010/09/17 2958
775   Viruses in the gut protect from infection  이성욱 2013/05/22 2945
774   Molecular scalpel hope for Duchenne muscular dystrophyBy James Gallagher  이성욱 2011/07/28 2940
773   Pluripotency not required !!!  이성욱 2010/01/28 2936
772   Autistic Mice Act a Lot Like Human Patients: Geneticists Develop Promising Mouse Model for Testing New Autism Therapies  이성욱 2011/10/06 2931
771   C형간염 진단 유전자검사 개발  이성욱 2013/03/07 2921
770   Why brain tumors hard to treat  이성욱 2010/11/23 2918
769   줄기세포 이식으로 HIV 감염 완치: 세계 3번째, 4번째의 HIV 완치 환자 등장  이성욱 2013/07/05 2907
768   More support for RNAi in clinic  이성욱 2010/03/23 2906

[이전 10개] [1]..[21][22][23][24] 25 [26][27][28][29][30]..[64] [다음 10개]
 

Copyright 1999-2024 Zeroboard / skin by ROBIN